Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2024-12-25T18:13:12.407Z Has data issue: false hasContentIssue false
  • English
  • Français

The cost of borderline personality disorder: societal cost of illness in BPD-patients

Published online by Cambridge University Press:  04 June 2007

A.D.I. van Asselt ,
C.D. Dirksen ,
A. Arntz  and
J.L. Severens
A.D.I. van Asselt*
Affiliation:
Department of Clinical Epidemiology and MTA, University Hospital Maastricht, Maastricht, The Netherlands
C.D. Dirksen
Affiliation:
Department of Clinical Epidemiology and MTA, University Hospital Maastricht, Maastricht, The Netherlands
A. Arntz
Affiliation:
Department of Clinical Psychological Science, Maastricht University, Maastricht, The Netherlands
J.L. Severens
Affiliation:
Department of Clinical Epidemiology and MTA, University Hospital Maastricht, Maastricht, The Netherlands Department of Health Organization, Policy, and Economics (HOPE), Maastricht University, Maastricht, The Netherlands
*
∗Corresponding author. Department of Clinical Epidemiology and Medical Technology Assessment, University Hospital Maastricht, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands. Tel.: +31 43 3875587; fax: +31 43 3874419. E-mail address: avas@kemta.azm.nl (A.D.I. van Asselt).
Get access

Abstract

Background

Borderline personality disorder (BPD) is a highly prevalent, chronic condition. Because of its very problematic nature BPD is expected to be associated with substantial societal costs, although this has never been comprehensively assessed.

Objective

Estimate the societal cost of BPD in the Netherlands.

Study Design

We used a prevalence-based bottom-up approach with a sample of 88 BPD patients who enrolled in a multicenter clinical trial comparing two kinds of outpatient psychotherapy. Costs were assessed by means of a structured interview, covering all healthcare costs, medication, informal care, productivity losses, and out-of-pocket expenses. Only BPD-related costs were included. All costs were expressed in Euros for the year 2000. A bootstrap procedure was performed to determine statistical uncertainty.

Patients

All patients had been diagnosed with BPD using DSM-IV criteria. Mean age was 30.5 years and 92% was female.

Results

Based on a prevalence of 1.1% and an adult population of 11,990,942, we derived that there were 131,900 BPD patients in the Netherlands. Total bootstrapped yearly cost of illness was €2,222,763,789 (€1,372,412,403–€3,260,248,300), only 22% was healthcare-related. Costs per patient were €16,852.

Conclusions

Although healthcare costs of non-institutionalized Borderline patients might not be disproportionate, total societal costs are substantial.

Keywords

Borderline personality disorderEconomics and psychiatryHealth economics
Type
Original article
Information
European Psychiatry , Volume 22 , Issue 6 , September 2007 , pp. 354 - 361
Copyright
Copyright © Elsevier Masson SAS 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association Diagnostic and statistical manual of mental disorders. fourth ed. Washington, D.C.: American Psychiatric Association; 1994.Google Scholar
Arntz, A., van den Hoorn, M., Cornelis, J., Verheul, R., van den Bosch, W.M., de Bie, A.J.Reliability and validity of the borderline personality disorder severity index. J Personal Disord 2003;17(1):45–59.CrossRefGoogle ScholarPubMed
Bateman, A., Fonagy, P.Psychotherapy for borderline personality disorder. Mentalization-based treatment Oxford: Oxford University Press; 2004.Google ScholarPubMed
Bender, D.S., Skodol, A.E., Pagano, M.E., Dyck, I.R., Grilo, C.M., Shea, M.T.et al.Prospective assessment of treatment use by patients with personality disorders. Psychiatr Serv 2006;57(2):254–257.CrossRefGoogle ScholarPubMed
Briggs, A.H., Wonderling, D.E., Mooney, C.Z.Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ 1997;6(4):327–340.3.0.CO;2-W>CrossRefGoogle ScholarPubMed
Brooner, R.K., King, V.L., Kidorf, M., Schmidt, C.W. Jr., Bigelow, G.E.Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psychiatry 1997;54(1):71–80.CrossRefGoogle ScholarPubMed
Central Bureau for Statistics Statline. Accessed in 2000.http://www.cbs.nl.Google Scholar
Dolan, P.Modeling valuations for EuroQol health states. Med Care 1997;35(11):1095–1108.CrossRefGoogle ScholarPubMed
Dolan, B.M., Coid, J.W.Psychopathic and antisocial personality disorders: treatment and research issues. London: Gaskell; 1993.Google Scholar
Efron, B., Tibshirani, R.J.An introduction to the bootstrap. London: Chapmann & Hall; 1993.CrossRefGoogle Scholar
Evers, S.M., Struijs, J.N., Ament, A.J., van Genugten, M.L., Jager, J.H., van den Bos, G.A.International comparison of stroke cost studies. Stroke 2004;35(5):1209–1215.CrossRefGoogle ScholarPubMed
First, M.B., Spitzer, R.L., Gibbon, M. Structured clinical Interview for DSM-IV Axis II personality disorders (SCID-II, version 2.0). New York State Psychiatric Institute; 1994.Google Scholar
Frankenburg, F.R., Zanarini, M.C.The association between borderline personality disorder and chronic medical illnesses, poor health-related lifestyle choices, and costly forms of health care utilization. J Clin Psychiatry 2004;65(12):1660–1665.CrossRefGoogle ScholarPubMed
GGZ. Figures from PiGGz regarding psychiatric hospitals, community health care centers, addiction treatment and forensic psychiatry. Annual report 1997. Utrecht: GGZ Nederland.Google Scholar
Giesen-Bloo, J., van Dyck, R., Spinhoven, P., van Tilburg, W., Dirksen, C., van Asselt, T.et al.Outpatient psychotherapy for borderline personality disorder: randomized trial of schema-focused therapy vs transference-focused psychotherapy. Arch Gen Psychiatry 2006;63(6):649–658.CrossRefGoogle ScholarPubMed
Goossens, M.E., Rutten-van Molken, M.P., Vlaeyen, J.W., van der Linden, S.M.The cost diary: a method to measure direct and indirect costs in cost-effectiveness research. J Clin Epidemiol 2000;53(7):688–695.CrossRefGoogle ScholarPubMed
Greeven, P.G.J.The inpatient treatment of forensic patients with a personality disorder (in Dutch). Deventer: Universiteit van Utrecht; 1997.Google Scholar
Grilo, C.M., McGlashan, T.H., Quinlan, D.M., Walker, M.L., Greenfeld, D., Edell, W.S.Frequency of personality disorders in two age cohorts of psychiatric inpatients. Am J Psychiatry 1998;155(1):140–142.CrossRefGoogle ScholarPubMed
Hodgson, T.A., Meiners, M.R.Cost-of-illness methodology: a guide to current practices and procedures. Milbank Mem Fund Q Health Soc 1982;60(3):429–462.CrossRefGoogle ScholarPubMed
Maier, W., Lichtermann, D., Klingler, T., Heun, R., Hallmayer, J.Prevalences of personality disorders (DSM-III-R) in the community. J Pers disorders 1992;6(3):187–196.CrossRefGoogle Scholar
McGovern, M.P., Xie, H., Segal, S.R., Siembab, L., Drake, R.E.Addiction treatment services and co-occurring disorders: Prevalence estimates, treatment practices, and barriers. J Subst Abuse Treat 2006;31(3):267–275.CrossRefGoogle ScholarPubMed
Morgenstern, J., Langenbucher, J., Labouvie, E., Miller, K.J.The comorbidity of alcoholism and personality disorders in a clinical population: prevalence rates and relation to alcohol typology variables. J Abnorm Psychol 1997;106(1):74–84.CrossRefGoogle Scholar
Oldham, J.M.Borderline personality disorder and suicidality. Am J Psychiatry 2006;163(1):20–26.CrossRefGoogle ScholarPubMed
Oldham, J.M., Skodol, A.E., Kellman, H.D., Hyler, S.E., Rosnick, L., Davies, M.Diagnosis of DSM-III-R personality disorders by two structured interviews: patterns of comorbidity. Am J Psychiatry 1992;149(2):213–220.Google ScholarPubMed
Oostenbrink, J.B., Bouwmans, C.A.M., Koopmanschap, M.A., Rutten, F.F.Manual for cost research. Methods and unit-prices for economic evaluations in health care (in Dutch). Amstelveen: College voor zorgverzekeringen; 2004. Updated version.Google Scholar
Palmer, S., Davidson, K., Tyrer, P., Gumley, A., Tata, P., Norrie, J.et al.The cost-effectiveness of cognitive behavior therapy for borderline personality disorder: results from the BOSCOT trial. J Personal Disord 2006;20(5):466–481.CrossRefGoogle ScholarPubMed
Paris, J., Zweig-Frank, H.A 27-year follow-up of patients with borderline personality disorder. Compr Psychiatry 2001;42(6):482–487.CrossRefGoogle ScholarPubMed
Pompili, M., Girardi, P., Ruberto, A., Tatarelli, R.Suicide in borderline personality disorder: a meta-analysis. Nord J Psychiatry 2005;59(5):319–324.CrossRefGoogle ScholarPubMed
Rendu, A., Moran, P., Patel, A., Knapp, M., Mann, A.Economic impact of personality disorders in UK primary care attenders. Br J Psychiatry 2002;181:62–66.CrossRefGoogle ScholarPubMed
Rice, D.P.Estimating the cost of illness. Washington: Department of Health, Education and Welfare; 1966.Google Scholar
Rounsaville, B.J., Kranzler, H.R., Ball, S., Tennen, H., Poling, J., Triffleman, E.Personality disorders in substance abusers: relation to substance use. J Nerv Ment Dis 1998;186(2):87–95.CrossRefGoogle ScholarPubMed
Samuels, J., Eaton, W.W., Bienvenu, O.J.3rd Brown, C.H., Costa, P.T. Jr., Nestadt, G.Prevalence and correlates of personality disorders in a community sample. Br J Psychiatry 2002;180:536–542.CrossRefGoogle Scholar
Severens, J.L., Mulder, J., Laheij, R.J., Verbeek, A.L.Precision and accuracy in measuring absence from work as a basis for calculating productivity costs in The Netherlands. Soc Sci Med 2000;51(2):243–249.CrossRefGoogle ScholarPubMed
Smith, K., Shah, A., Wright, K., Lewis, G.The prevalence and costs of psychiatric disorders and learning disabilities. Br J Psychiatry 1995;166(1):9–18.CrossRefGoogle ScholarPubMed
Timmerman, I.G., Emmelkamp, P.M.The relationship between traumatic experiences, dissociation, and borderline personality pathology among male forensic patients and prisoners. J Personal Disord 2001;15(2):136–149.CrossRefGoogle ScholarPubMed
Torgersen, S., Kringlen, E., Cramer, V.The prevalence of personality disorders in a community sample. Arch Gen Psychiatry 2001;58(6):590–596.CrossRefGoogle Scholar
van den Berg, B., Brouwer, W.B., Koopmanschap, M.A.Economic valuation of informal care. An overview of methods and applications. Eur J Health Econ 2004;5(1):36–45.CrossRefGoogle ScholarPubMed
van den Brink, M., van den Hout, W.B., Stiggelbout, A.M., Putter, H., van de Velde, C.J., Kievit, J.Self-reports of health-care utilization: diary or questionnaire?. Int J Technol Assess Health Care 2005;21(3):298–304.CrossRefGoogle ScholarPubMed
van den Brink, M., van den Hout, W.B., Stiggelbout, A.M., van de Velde, C.J., Kievit, J.Cost measurement in economic evaluations of health care: whom to ask?. Med Care 2004;42(8):740–746.CrossRefGoogle Scholar
Verheul, R., Hartgers, C., Van den Brink, W., Koeter, M.W.The effect of sampling, diagnostic criteria and assessment procedures on the observed prevalence of DSM-III-R personality disorders among treated alcoholics. J Stud Alcohol 1998;59(2):227–236.CrossRefGoogle ScholarPubMed
Weaver, T.L., Clum, G.A.Early family environments and traumatic experiences associated with borderline personality disorder. J Consult Clin Psychol 1993;61(6):1068–1075.CrossRefGoogle ScholarPubMed
Weertman, A., Arntz, A., Kerkhofs, M.L.M.Gestructureerd klinisch interview voor DSM-IV persoonlijkheidsstoornissen (Ned. bewerking van First, et al. SCID-II, version 2.0 1996). Maastricht: Universiteit Maastricht; 1996.Google Scholar
Zanarini, M.C., Frankenburg, F.R., Hennen, J., Reich, D.B., Silk, K.R.Prediction of the 10-year course of borderline personality disorder. Am J Psychiatry 2006;163(5):827–832.CrossRefGoogle ScholarPubMed
Zanarini, M.C., Frankenburg, F.R., Hennen, J., Silk, K.R.Mental health service utilization by borderline personality disorder patients and Axis II comparison subjects followed prospectively for 6 years. J Clin Psychiatry 2004;65(1):28–36.CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.